- The pharmaceuticals packaging testing equipment market in the Middle East and Africa is driven by growing pharmaceutical manufacturing activities, increasing regulatory compliance requirements, and rising focus on drug safety and product quality across the supply chain
- The market growth is supported by expanding healthcare infrastructure, government initiatives to enhance pharmaceutical standards, and the need to prevent counterfeit drugs through stringent packaging integrity testing
- Saudi Arabia holds a dominant market share of 38.75% in 2024, owing to its strong pharmaceutical manufacturing base, regulatory enforcement by the SFDA, and investments aligned with Vision 2030 that promote healthcare and industrial growth
- By type, the equipment segment is expected to dominate the market, as pharmaceutical companies and contract research organizations increasingly adopt advanced and automated packaging testing technologies for quality assurance
- By end user, pharmaceutical companies remain the largest consumers of packaging testing equipment, followed by contract research organizations, government bodies, research institutions, and specialized testing laboratories, reflecting a diverse and growing ecosystem for pharmaceutical quality control
